Similarly, Zhang and colleagues found in a colon cancer cell line, knocking down ERCC1 protein expression increased the response to cells to CPT-11 in combination with ABT-888 as measured by γ-H2AX phosphorylation [26]. The gene discussed is ERCC1; the disease is colonic neoplasm.